Physician profile
Guido H Ring
NPI 1174595904
$1,619.00
in general payments reported to CMS, 2019-2025
22 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $350 · 2020: $289 · 2021: $676 · 2022: $304.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $324.19 | 2019-2021 | |
| Abbott Laboratories | $273.29 | 2021 | |
| Allergan, INC. | $170.55 | 2019-2020 | |
| Avanir Pharmaceuticals, INC. | $168.40 | 2021-2022 | |
| Astrazeneca Pharmaceuticals LP | $136.57 | 2022 | |
| Amgen INC. | $74.10 | 2019-2022 | |
| Abbvie INC. | $66.15 | 2020-2021 | |
| Novo Nordisk INC | $59.67 | 2020-2022 | |
| Electromed, INC. | $54.84 | 2019-2021 | |
| Nestle Healthcare Nutrition INC. | $40.57 | 2022 | |
| Sanofi-Aventis U.S. LLC | $38.44 | 2021 | |
| Janssen Pharmaceuticals, INC | $38.00 | 2020-2021 | |
| Novartis Pharmaceuticals Corporation | $35.74 | 2022 | |
| Vifor Pharma, INC. | $20.64 | 2022 | |
| Aurinia Pharma U.S., INC. | $20.17 | 2021 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teva Pharmaceuticals USA, INC. | $17.74 | 2021 | |
| Fresenius USA Marketing, INC. | $17.61 | 2019 | |
| Akebia Therapeutics INC | $13.04 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $12.76 | 2020 | |
| Alexion Pharmaceuticals, INC. | $12.67 | 2021 | |
| Medtronic, INC. | $11.96 | 2022 | |
| Ultragenyx Pharmaceutical INC. | $11.90 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Guido Ring listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.